Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019

Peer Review reports

Original Submission
22 Jul 2021	Submitted	Original manuscript
19 Aug 2021	Reviewed	Reviewer Report
9 Oct 2021	Reviewed	Reviewer Report
10 Nov 2021	Author responded	Author comments - Matthäus Lottes
Resubmission - Version 2
10 Nov 2021	Submitted	Manuscript version 2
16 Nov 2021	Author responded	Author comments - Matthäus Lottes
Resubmission - Version 3
16 Nov 2021	Submitted	Manuscript version 3
6 Dec 2021	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
7 Dec 2021	Editorially accepted
13 Jan 2022	Article published	10.1186/s12913-021-07390-4

Back to article page